RNA Supply Chain Resources

1. The Evolution Of Nucleotide Production 4/2/2025

   From harsh chemicals to gentle enzymes: Explore the groundbreaking shift in nucleotide synthesis, making drug manufacturing cleaner, greener, and more efficient.

2. Building Stability Through Integrated Cryopreservation 3/30/2026

   Early integration of standardized, GMP-aligned cryopreservation improves consistency, documentation, and scalability in advanced therapy programs as they progress toward regulatory submissions.

3. Accelerate Your Trials With An End‑To‑End Supply Chain Model 4/28/2026

   An end-to-end supply chain model helps clinical trials move faster while maintaining visibility, control, and risk management across complex, temperature‑sensitive, and global operations.

4. Consolidating The Supply Chain For mRNA 2/12/2024

   Learn about the first end-to-end cGMP facility that was developed for mRNA manufacturing to address the shortage of CDMOs and the inadequate and inefficient supply chain options for sourcing GMP mRNA.

5. How Operational Efficiency Shapes Late-Phase Manufacturability 6/26/2026

   Prioritize operational efficiency over early-stage flexibility to scale advanced therapies. Standardized workflows and qualified shipping lanes reduce variability for predictable late-phase success.

6. Lipid Nanoparticles Beyond Vaccines: New Frontiers 10/7/2026

   As RNA therapeutics move into chronic, personalized, and organ-specific uses, delivery design must shift toward repeat-dose tolerability, storage stability, and targeting that reaches beyond the liver.

7. Accelerate Efficiency By Decoupling Collection From Manufacturing 6/26/2026

   Cryopreservation eliminates rigid timelines by decoupling collection from production, providing the flexibility needed to optimize facility use and stabilize advanced therapy supply chains.

8. Moderna's Regulatory Journey: 3 Takeaways To Foster The mRNA Renaissance 1/2/2024

   The story of how Moderna brought one of the first mRNA vaccines to the market has all the makings of a legend we will pass down through generations. However, unlike the legends of King Arthur or The Fountain of Youth, we can celebrate that Moderna’s legendary journey was — and still is — real. Not only did the mRNA vaccines help return life to normal, but they also kickstarted the mRNA therapeutic renaissance we’re happily experiencing today.

9. mRNA Synthesis Reagents And Manufacturing 8/14/2023

   As novel mRNA therapies are starting to enter clinical stages of development, Aldevron is providing critical support in a number of ways with specialized products and services.

10. Move Beyond LAL 4/14/2026

    Uncover how how switching from LAL to rFC can enhance sustainability, improve testing reliability, and strengthen supply-chain resilience in endotoxin testing.